Pharmacokinetics of intravenous magnesium isoglycyrrhizinate after a single dose in patients with chronic hepatic impairment
- At: 2007 FIP Congress in Beijing (China)
- Type: Poster
- By: SUN, Li (RenJi hospital, Shanghai, China)
- Co-author(s): Shen, jinfang (RenJi hospital, SHANGHAI, China)
Mao, yimin (RenJi hospital, SHANGHAI, China)
Zeng, minde (RenJi hospital, SHANGHAI, China)
OBJECTIVE To study the pharmacokinetics of intravenous magnesium isoglycyrrhizinate injection in 10 patients with chronic hepatic impairment. METHODS Single doses of 100mg magnesium isoglycyrrhizinate were administrated to patients with chronic hepatic impairment by iv infusion. The concentrations of magnesium isoglycyrrhizinate in plasma were.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.